Official press release from Taysha giving more detail of their REVEAL paediatric gene therapy trial with sites in the US and UK.
Official press release from Taysha giving more detail of their REVEAL paediatric gene therapy trial with sites in the US and UK.
Rett Syndrome Europe welcomes the positive CHMP opinion for Daybu (trofinetide), a meaningful milestone for families affected by Rett syndrome across Europe.
Taysha Gene Therapies has shared positive longer-term interim data from its investigational gene therapy TSHA-102, with dosing now complete in the pivotal…
Neurogene has announced the successful completion of enrollment in the EMBOLDEN trial of NGN-401, an investigational gene therapy for Rett syndrome. The…